Product NDC: | 63323-401 |
Proprietary Name: | Aztreonam |
Non Proprietary Name: | AZTREONAM |
Active Ingredient(s): | 1 g/1 & nbsp; AZTREONAM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-401 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065439 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091105 |
Package NDC: | 63323-401-20 |
Package Description: | 10 VIAL in 1 TRAY (63323-401-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Code | 63323-401-20 |
Proprietary Name | Aztreonam |
Package Description | 10 VIAL in 1 TRAY (63323-401-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Product NDC | 63323-401 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AZTREONAM |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20091105 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | AZTREONAM |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient] |